AAOS recommends against vertebroplasty
This article was originally published in The Gray Sheet
Executive Summary
American Academy of Orthopaedic Surgeons is recommending against use of vertebroplasty to treat symptomatic osteoporotic spinal compression fractures, according to a Sept. 24 clinical practice 1guideline. Stephen Esses, M.D., Southwest Orthopedic Group, who chaired the volunteer physician workgroup that developed the guideline, said the group reviewed literature over several years and concluded "vertebroplasty does not provide the types of benefits that it was previously thought to provide." Vertebroplasty is the percutaneous injection of polymethylmethacrylate (PMMA) into a fractured vertebral body to alleviate pain and stabilize the spine. The recommendation against the procedure is largely based on two randomized studies published in the New England Journal of Medicine finding that vertebroplasty provided no lasting benefit over sham procedures (2"The Gray Sheet" Aug. 10, 2009)
You may also be interested in...
Vertebroplasty Shows No More Benefit Than Sham Procedures In Trials
The first two blinded, randomized, placebo-controlled trials of vertebroplasty treatment for spinal fractures suggest that the procedure may have no lasting benefit, researchers report in the Aug. 6 New England Journal of Medicine
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.